Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
318 |
issn |
1523-3804 1534-6242 |
issueIdentifier |
4 |
pageRange |
312-318 |
publicationName |
Current Atherosclerosis Reports |
startingPage |
312 |
bibliographicCitation |
Redman AR, Allen LC. Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study. Curr Atheroscler Rep. 2002 Jul;4(4):319–25. doi: 10.1007/s11883-002-0011-9. PMID: 12052284. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ac855d36cba8cd681314087235b6868 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b05584e136181d26d96715bfbabf8de |
date |
200207 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/12052284 https://doi.org/10.1007/s11883-002-0011-9 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21922 https://portal.issn.org/resource/ISSN/1534-6242 https://portal.issn.org/resource/ISSN/1523-3804 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Warfarin versus aspirin in the secondary prevention of stroke: The WARSS study |
discusses |
http://id.nlm.nih.gov/mesh/M0001380 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0022871 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746 |